Association between the cumulative dose of cyclosporine and liver enzyme abnormalities in dermatology patients managed with a low‐dose regimen
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15855
Abstract: Cyclosporine (CsA) is an immunosuppressive agent that specifically inhibits T cell‐related immune responses. There is little evidence regarding the association between low‐dose CsA administration and abnormal hepatic function in dermatology patients. This study aimed to… read more here.
Keywords: liver enzyme; dose csa; dose; dermatology ... See more keywords